Microbiome Connect: EUROPE 2023

Microbiome Connect: Where innovation meets industry

Uniting industry leaders across Europe in therapeutic drug development to share insights, drive investment & build new partnerships to bring innovative products to patients

DOWNLOAD THE AGENDA
AMSTERDAM, NETHERLANDS
5-6 July, 2023

MICROBIOME CONNECT IS THE LEADING PARTNERING CONFERENCE FOR MICROBIOME THERAPEUTICS & LIVE BIOTHERAPEUTIC PRODUCTS

It’s a chance for senior executives to address shared challenges around innovative therapeutic development, build meaningful partnerships, and sharpen their R&D and commercial strategies. Bringing together the whole microbiome therapeutics ecosystem – from investors and large pharmaceutical companies through to the most pioneering biotechs, academic institutions and solution providers – it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.

With recent approvals for C. difficile from Rebiotix a Ferring Company, Seres Therapeutics and BiomeBank, Microbiome Connect highlights the next wave of cutting-edge science poised to impact this field – with sessions on preclinical and clinical data alongside discussions around manufacturing and diagnostic development.

WHY SHOULD YOU ATTEND?

Investment Trends

Hear from investors and pharma on how to ensure they have confidence in your product and what therapeutic modalities are ripe for investment in 2023 & beyond.

Emerging Therapeutics

Join leading biotechs at the forefront of innovation who are developing pioneering therapeutics across Europe. From Women’s Health & Neuroscience through to Immuno-Oncology & Wound Care, learn how your microbiome drug can meet unmet medical needs.

Bioprocessing Strategies

Create and implement regulatory-adherent manufacturing strategies to bring innovative therapeutics to the clinic. Gain a handle on your CMC and find the partners you need to ensure stability & potency in your manufacturing process.

Biomarker Data

Establish and leverage biomarkers to streamline your route to the clinic, with consideration of how biomarker data sets can make your therapeutic stand above the crowd and drive investment.

HEAR FROM OUR COMMUNITY

WHO YOU'LL MEET

50%
Biotechs
20%
Pharma & Investors
10%
Academia
20%
Service Providers

Biotechs

Pharma & Investors

Academia

Service Providers

200+
Attendees
40+
Industry Leading Speakers
100+
Contributing Organisations

SNAPSHOT OF 2022 ATTENDEES

EVENT SCHEDULE

The 2023 agenda is here! Fill out the short form to access a copy immediately.

What's new this year?

1) Improved Networking Opportunities

Meet your next collaborator, with a revamped programme allowing for more business critical partnering opportunities than ever with over 8 hours of dedicated networking time

2) More Key Players

Meet the game changers from across the industry, with new companies confirmed for 2023 including Mikrobiomik, Neobe Therapeutics, Integral Solutions, Freya Biosciences, ActoBio Therapeutics and Microviable Therapeutics

3) Business Strategy Sessions

In a market still in its infancy, its critical to gain the strategic insights you need to ensure your business thrives – and we’re bringing together the late-stage companies paving the way in Europe for microbiome therapeutics to share their guidance on running a robust biotech

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.


DOWNLOAD THE AGENDA

2023 SPEAKER FACULTY

 

Staffan Stromberg

CEO
Infant Bacterial Therapeutics

Staffan Stromberg

CEO
Infant Bacterial Therapeutics

Staffan Stromberg

CEO
Infant Bacterial Therapeutics
 

Pedro Correa de Sampaio

CEO
Neobe Therapeutics

Pedro Correa de Sampaio

CEO
Neobe Therapeutics

Pedro Correa de Sampaio

CEO
Neobe Therapeutics
 

Romain Daillere

Head of Preclinical Research, Co-Founder
Everimmune

Romain Daillere

Head of Preclinical Research, Co-Founder
Everimmune

Romain Daillere

Head of Preclinical Research, Co-Founder
Everimmune
 

Jean-Luc Marsat

CEO
Everimmune

Jean-Luc Marsat

CEO
Everimmune

Jean-Luc Marsat

CEO
Everimmune
 

Sandrine Claus

CSO
YSOPIA

Sandrine Claus

CSO
YSOPIA

Sandrine Claus

CSO
YSOPIA
 

Benjamin Hadida

CEO & Co-founder
Exeliom

Benjamin Hadida

CEO & Co-founder
Exeliom

Benjamin Hadida

CEO & Co-founder
Exeliom
 

Sam Possemiers

CEO
MRM Health

Sam Possemiers

CEO
MRM Health

Sam Possemiers

CEO
MRM Health
 

Tomas De Wouters

CEO
PharmaBiome

Tomas De Wouters

CEO
PharmaBiome

Tomas De Wouters

CEO
PharmaBiome
 

Osnat Tirosh

Head of Microbiome Research and Innovation
Biomica

Osnat Tirosh

Head of Microbiome Research and Innovation
Biomica

Osnat Tirosh

Head of Microbiome Research and Innovation
Biomica
 

Juan Basterra

CEO
Mikrobiomik

Juan Basterra

CEO
Mikrobiomik

Juan Basterra

CEO
Mikrobiomik
 

Karine Roget

CSO
Nexbiome Tx

Karine Roget

CSO
Nexbiome Tx

Karine Roget

CSO
Nexbiome Tx
 

Denise Kelly

Investment Advisor
Seventure Partners

Denise Kelly

Investment Advisor
Seventure Partners

Denise Kelly

Investment Advisor
Seventure Partners
 

Eric Van der Helm

VP Scientific Affairs, Bioinformatics & Automation
SNIPR Bio

Eric Van der Helm

VP Scientific Affairs, Bioinformatics & Automation
SNIPR Bio

Eric Van der Helm

VP Scientific Affairs, Bioinformatics & Automation
SNIPR Bio
 

Anna Chwalibog

CEO, Co-founder
Integral Solutions

Anna Chwalibog

CEO, Co-founder
Integral Solutions

Anna Chwalibog

CEO, Co-founder
Integral Solutions
 

Evelina Vågesjö, PhD MBA

CEO
Ilya Pharma

Co-founder of and developed the concept during PhD 2011-2016, is now CEO and heading the drug and business development in Ilya Pharma. Also BSc in Management Accounting and finished an MBA 2018. Raised >4.3 M€ in grant funding to the project, lead the first private share issue in 2017 and designed stock option programs for key employees.  

Evelina Vågesjö, PhD MBA

CEO
Ilya Pharma

Evelina Vågesjö, PhD MBA

CEO
Ilya Pharma

Co-founder of and developed the concept during PhD 2011-2016, is now CEO and heading the drug and business development in Ilya Pharma. Also BSc in Management Accounting and finished an MBA 2018. Raised >4.3 M€ in grant funding to the project, lead the first private share issue in 2017 and designed stock option programs for key employees.  

 

Nathalie Corvaia

CSO
MaaT Pharma

Nathalie Corvaia

CSO
MaaT Pharma

Nathalie Corvaia

CSO
MaaT Pharma
 

Chrysi Sergaki

Principal Investigator - Microbiome Group Leader
MHRA

Chrysi Sergaki

Principal Investigator - Microbiome Group Leader
MHRA

Chrysi Sergaki

Principal Investigator - Microbiome Group Leader
MHRA
 

Yuri Martina

CMO
Destiny Pharma

Yuri Martina

CMO
Destiny Pharma

Yuri Martina

CMO
Destiny Pharma
 

Kristen Albright

CEO
Prokarium

Kristen Albright

CEO
Prokarium

Kristen Albright

CEO
Prokarium
 

Steve Emery

CSO
Chain Biotech

Steve Emery

CSO
Chain Biotech

Steve Emery

CSO
Chain Biotech
 

Sarah Lebeer

Professor
University of Antwerp

Sarah Lebeer

Professor
University of Antwerp

Sarah Lebeer

Professor
University of Antwerp
 

Ruben Vazquez Uribe

Co-principal Investigator
Novo Nordisk Foundation Center for Biosustainability

Ruben Vazquez Uribe

Co-principal Investigator
Novo Nordisk Foundation Center for Biosustainability

Ruben Vazquez Uribe

Co-principal Investigator
Novo Nordisk Foundation Center for Biosustainability
 

Samantha Coulson

Head of Clinical Research
Servatus

Samantha Coulson

Head of Clinical Research
Servatus

Samantha Coulson

Head of Clinical Research
Servatus
 

Nicolas Pichon

Head of Production
Servatus

Nicolas Pichon

Head of Production
Servatus

Nicolas Pichon

Head of Production
Servatus
 

Adam Baker

Director of Sciences
Chr. Hansen

Adam Baker

Director of Sciences
Chr. Hansen

Adam Baker

Director of Sciences
Chr. Hansen
 

Harriet Schellekens

Lecturer
University College Cork

Harriet Schellekens

Lecturer
University College Cork

Harriet Schellekens

Lecturer
University College Cork
 

Pilar Manrique Ronquillo

Research Scientist
Microviable Tx

Pilar Manrique Ronquillo

Research Scientist
Microviable Tx

Pilar Manrique Ronquillo

Research Scientist
Microviable Tx
 

Rosanne Hertzberger

PI
Vrije Universiteit Amsterdam

Rosanne Hertzberger

PI
Vrije Universiteit Amsterdam

Rosanne Hertzberger

PI
Vrije Universiteit Amsterdam
 

Lothar Steidler

CTO
ActoBio Tx

Lothar Steidler

CTO
ActoBio Tx

Lothar Steidler

CTO
ActoBio Tx
 

Amine Zorgani

Director, R&D
S-Biomedic

Amine Zorgani

Director, R&D
S-Biomedic

Amine Zorgani

Director, R&D
S-Biomedic
 

Jonathan Swann

Professor
University of Southampton

Jonathan Swann

Professor
University of Southampton

Jonathan Swann

Professor
University of Southampton
 

Selin Bolca

Head of Development
MRM Health

Selin Bolca

Head of Development
MRM Health

Selin Bolca

Head of Development
MRM Health
 

Johan E.T. van Hylckama Vlieg

Chief Scientific Officer
Freya Biosciences

Johan E.T. van Hylckama Vlieg

Chief Scientific Officer
Freya Biosciences

Johan E.T. van Hylckama Vlieg

Chief Scientific Officer
Freya Biosciences

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

TICKET PRICE WILL INCREASE IN:

— June 9, 2023 —

Saturday, May 20, 2023 to Friday, June 9, 2023
Tier 1 - Academics & Emerging Biotechs
€1,499
Saturday, May 20, 2023 to Friday, June 9, 2023
Tier 2 - Established Biotechs & Pharma
€1,999
Saturday, May 20, 2023 to Friday, June 9, 2023
Tier 3 - Solution Providers
€3,999
Preparing registration...

GET INVOLVED

Sponsorship

Let us create a bespoke package based on your specific objectives, and showcase your brand to the microbiome community.

Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

Contact [email protected]

Media & Press

Connecting the microbiome community is essential for progress in the field.

We'd love to hear from you and how we can support one another to connect leaders in the industry and share important insights.

Contact [email protected] if you have any questions. For more information on marketing solutions and digital opportunities, download the Media Kit below.

MICROBIOME CONNECT MEDIA KIT

For more information on webinars, roundtables, content marketing packages, interviews and bespoke opportunities to accelerate microbial innovation with Microbiome Connect, download the Media Kit below.

DOWNLOAD THE MEDIA KIT

If you have any questions, please contact Simon Pickles, Senior Commercial Partnerships Manager, [email protected].

POSTER SUBMISSIONS

Are you looking to showcase your recent work to the Microbiome community?

Our dedicated poster session is the perfect way to get your research noticed, ideal for PhD students or Post-Doctoral researchers. In order to present a poster, you need to register as a delegate. 

Please note that there is limited space available, and poster space is assigned on a first-come, first-served basis (subject to checks and successful registration). At the event, your presentation will be displayed in a dedicated poster area. The poster presentation session time of taking place is to be confirmed.

Poster abstract submission deadline is 7pm (BST) on Friday June 2, 2023

Posters should be a one page PDF in portrait orientation.

Abstracts received after this time may not be accepted so please submit your abstract as soon as possible! Academics that submit a poster abstract before June 2 2023 get a 100 discount!

Posters should be sized A0 (841mm x 1189mm) in portrait orientation.

If you have any questions please contact [email protected] 

Click HERE to make a submission.

PARTNERS

Gold Partners

Silver Partner

EVENT PARTNER

Venue

Hotel Okura Amsterdam, Ferdinand Bolstraat 333, 1072 LH Amsterdam, Netherlands

Microbiome Connect invites you to join us at Hotel Okura on the 5th-6th July 2023.

Discounted rooms available to attendees here.

Dev_

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us